Standard Versus Alternating Non-cross-resistant Chemotherapy in Extensive Small Cell Lung Cancer: An EORTC Phase III Trial

Author： Postmus P.E.   Scagliotti G.   Groen H.J.M.   Gozzelino F.   Burghouts J.T.W.   Curran D.   Sahmoud T.   Kirkpatrick A.   Giaccone G.   Splinter T.A.W.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.9, 1996-08, pp. : 1498-1503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

By Paccagnella A.   Favaretto A.   Oniga F.   Barbieri F.   Ceresoli G.   Torri W.   Villa E.   Verusio C.   Cetto G.L.   Santo A.   De Pangher V.   Artioli F.   Cacciani G.C.   Parodi G.   Soresi F.   Ghi M.G.   Morabito A.   Biason R.   Giusto M.   Mosconi P.   Chiarion Sileni V.   GSTPV Gruppo di Studio Tumori Polmonari del Veneto  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 83-91

Elsevier

Access to resources Recommend Favorite

Rapidly Alternating Combination of Cisplatin-based Chemotherapy and Hyperfractionated Accelerated Radiotherapy in Split Course for Stage IIIA and Stage IIIB Non-small Cell Lung Cancer: Results of a Phase I-II Study by the GOTHA Group

By Alberto P.   Mirimanoff R.O.   Mermillod B.   Leyvraz S.   Nagy-Mignotte H.   Bolla M.   Wellmann D.   Moro D.   Brambilla E.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer - results of the EORTC 08912 phase I/II study

By Uitterhoeve A.L.J.   Belderbos J.S.A.   Koolen M.G.J.   van der Vaart P.J.M.   Rodrigus P.T.R.   Benraadt J.   Koning C.C.M.   Gonzalez Gonzalez D.   Bartelink H.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 592-600

Elsevier

Access to resources Recommend Favorite

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Benk J.   Chemaissani A.   Scholtze J.   Lorenz C.   Niestroy A.   Dalhoff K.   Muller T.   Walter T.   Durk H.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 583-590

Elsevier

Access to resources Recommend Favorite

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Durk H.   Kneba M.   Dickgreber N.   Welte T.   Muller T.   Scholtze J.   Graeven U.   Jasiewicz Y.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 654-660

Elsevier

Access to resources Recommend Favorite